A Highly Sensitive CRISPR‐Empowered Surface Plasmon Resonance Sensor for Diagnosis of Inherited Diseases with Femtomolar‐Level Real‐Time Quantification. Issue 14 (27th March 2022)

• Record Type: Journal Article
• Authors: Zheng, Fei; Chen, Zhi; Li, Jingfeng; Wu, Rui; Zhang, Bin; Nie, Guohui; Xie, Zhongjian; Zhang, Han
• Is Part Of: Advanced science. Volume 9:Issue 14(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-03-27
• Subjects: biosensor -- clustered regularly interspaced short palindromic repeats (CRISPR) -- nucleic acid detection -- surface plasmon resonance -- two‐dimensional materials; Science -- Periodicals; 505
• DOI: 10.1002/advs.202105231
• Languages: English
• ISSNs: 2198-3844

Abstract

Abstract: The clustered regularly interspaced short palindromic repeats (CRISPR) molecular system has emerged as a promising technology for the detection of nucleic acids. Herein, the development of a surface plasmon resonance (SPR) sensor that is functionalized with a layer of locally grown graphdiyne film, achieving excellent sensing performance when coupled with catalytically deactivated CRISPR‐associated protein 9 (dCas9), is reported. dCas9 protein is immobilized on the sensor surface and complexed with a specific single‐guide RNA, enabling the amplification‐free detection of target sequences within genomic DNA. The sensor, termed CRISPR‐SPR‐Chip, is used to successfully analyze recombinant plasmids with only three‐base mutations with a limit of detection as low as 1.3 fM. Real‐time monitoring CRISPR‐SPR‐Chip is used to analyze clinical samples of patients with Duchenne muscular dystrophy with two exon deletions, which are detected without any pre‐amplification step, yielding significantly positive results within 5 min. The ability of this novel CRISPR‐empowered SPR (CRISPR‐eSPR) sensing platform to rapidly, precisely, sensitively, and specifically detect a target gene sequence provides a new on‐chip optic approach for clinical gene analysis. Abstract : This paper presents a surface plasmon resonance (SPR) based, femtomolar‐level, pre‐amplification‐free, real‐time genomic DNAs quantification platform "CRISPR‐eSPR". This unprecedented specificity and efficiency are achieved by the innovative marriage of the unique sequence‐specific recognizing ability of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system and the superior sensitivity of the 2D‐material enforced Surface Plasmon Resonance sensor. The feasibility of clinical diagnosis has been strongly proved.